SCHEMBL8555940

SCHEMBL8555940

CON=C(C(=O)Oc1ccc(OCc2cccc(-c3ccccc3)n2)cc1)c1ccc(OCc2cccc(-c3ccccc3)n2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA3 P0DMS8 1/20 0.41
GPBAR1 Q8TDU6 1/20 0.41
KCNH2 Q12809 1/20 0.40
MRGPRX4 Q96LA9 1/20 0.39
PDE10A Q9Y233 3/20 0.38
PARP10 Q53GL7 1/20 0.38
HIF1A Q16665 3/20 0.37
ALOX5 P09917 1/20 0.37
MAPK14 Q16539 1/20 0.37
SMO Q99835 1/20 0.37
KDM4E B2RXH2 3/20 0.36
MAPT P10636 3/20 0.36
GAA P10253 1/20 0.36
RAB9A P51151 1/20 0.36
ALDH1A1 P00352 1/20 0.36
LMNA P02545 1/20 0.36
HPGD P15428 1/20 0.36
ALOX15 P16050 1/20 0.36
TSHR P16473 1/20 0.36
MAPK1 P28482 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8559814 0.89 PARP10 (0.45) ADORA3GPBAR1PDE10APARP10HIF1A
SCHEMBL8557149 0.85 KMT2A (0.38) ADORA3GPBAR1HIF1AKDM4EMAPT
SCHEMBL8556878 0.84 PPARD (0.50) ADORA3ALOX5KDM4EMAPTRAB9A
SCHEMBL8554714 0.82 PARP10 (0.57) PARP10MAPK14SMOKDM4EMAPT
SCHEMBL8559076 0.82 KMT2A (0.40) GPBAR1PARP10ALOX5MAPK14SMO
SCHEMBL8554930 0.81 GPBAR1 (0.62) GPBAR1PDE10AALOX5
SCHEMBL8555090 0.80 GPBAR1 (0.61) GPBAR1PDE10AALOX5
SCHEMBL8557020 0.80 GPBAR1 (0.46) GPBAR1PDE10AHIF1AALOX5MAPT
SCHEMBL8626716 0.77 NPC1 (0.54) ALOX5KDM4EMAPTRAB9AALDH1A1
SCHEMBL8622650 0.76 NPC1 (0.53) ALOX5KDM4EMAPTRAB9AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5714488-A FOR TREATMENT OF ALLERGIC AND INFLAMMATORY DISEASE STATES ABBOTT LABORATORIES (US) 1998-02-03 US disclosed